Request for Information: Oseltamivir and Zanamivir
In plain English
The notice doesn't say
Who holds it now
Last won by Reliance Medical Ltd in Jun 2026, for £3.
- Combined Needles and Syringes Lot 1Reliance Medical Ltd £3
- Pralidoxime ChlorideBaxter Healthcare Ltd
- Atropine and Ciprofloxacin 2024-2025Nationwide Healthcare Solutions LTD £35m
What you're up against
- The last two awards went to different firms: this buyer has changed supplier before.
- 3 different firms won this buyer's 3 awards for this kind of work since 2023.
- It last went for £3 in 2026.
The notice as published
UKHSA is inviting suppliers to participate in a preliminary market engagement exercise for Oseltamivir and Zanamivir through this Request for Information (RFI), in accordance with the Procurement Act 2023. The purpose of this exercise is to gather information on available products, supplier capability, and market conditions to inform a potential future procurement.